Integer (ITGR) Competitors

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Which has more volatility and risk, BDSX or ITGR?

Biodesix has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Integer has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Do analysts rate BDSX or ITGR?

Biodesix presently has a consensus price target of $1.75, suggesting a potential upside of 473.02%. Integer has a consensus price target of $145.00, suggesting a potential upside of 19.05%. Given Biodesix's higher probable upside, equities analysts clearly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Integer	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00

Is BDSX or ITGR more profitable?

Integer has a net margin of 4.38% compared to Biodesix's net margin of -54.28%. Integer's return on equity of 11.95% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-54.28%	-167.28%	-39.96%
Integer	4.38%	11.95%	6.04%

Do insiders and institutionals have more ownership in BDSX or ITGR?

21.0% of Biodesix shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 30.1% of Biodesix shares are held by company insiders. Comparatively, 2.2% of Integer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has higher earnings and valuation, BDSX or ITGR?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$71.32M	0.63	-$42.93M	-$0.29	-1.05
Integer	$1.72B	2.48	$119.90M	$2.11	57.73

Does the media refer more to BDSX or ITGR?

In the previous week, Integer had 2 more articles in the media than Biodesix. MarketBeat recorded 3 mentions for Integer and 1 mentions for Biodesix. Integer's average media sentiment score of 0.86 beat Biodesix's score of 0.00 indicating that Integer is being referred to more favorably in the news media.

Company	Overall Sentiment
Biodesix	Neutral
Integer	Positive

Summary

Integer beats Biodesix on 15 of the 17 factors compared between the two stocks.